ONDANSETRON HCL 8 MG TABLET
For 30 tablets
Pharmacies pay
$2.34 filed
30 × $0.07811 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part B pays
$3.84 derived
30 × $0.128 per EA, Part B limit
Medicare's price is not your price.
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
The spread
1.6× estimated
Medicare pays 1.6× what pharmacies pay.
12 labelers share HCPCS Q0162 on the CMS crosswalk, so its payment limit is an average across all their products billed under that code, not this NDC’s own price. (Counted once each though written more than one way: “PREFERRED PHARMACEUTICALS, INC.” and “Preferred Pharmaceuticals Inc”.)
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Cost-plus estimate
$7.69 estimated
$2.34 + $0.35 (15%) + $5.00 fee per fill = $7.69
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ONDANSETRON HCL 8 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “ondansetron” and “ondansetron hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.
FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.
FDA lists 10 labelers (the companies named on the label) for its NDCs, among them Major Pharmaceuticals, NorthStar Rx LLC and AvPAK.
FDA’s Established Pharmacologic Class for it is Serotonin-3 Receptor Antagonist.
The NADAC file of 2026-10-14 prices it under 16 NDCs (National Drug Codes); the FDA directory lists 14 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.34 for 30 tablets (30 × $0.07811 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 10 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Aurobindo Pharma Limited | 2 | $0.07811 per EA filed |
| Chartwell RX, LLC | 2 | $0.07811 per EA filed |
| Natco Pharma USA LLC | 2 | $0.07811 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.07811 per EA filed |
| American Health Packaging | 1 | $0.07811 per EA filed |
| AvPAK | 1 | $0.07811 per EA filed |
| Dr. Reddy's Laboratories Limited | 1 | $0.07811 per EA filed |
| Glenmark Pharmaceuticals Inc., USA | 1 | $0.07811 per EA filed |
| Major Pharmaceuticals | 1 | $0.07811 per EA filed |
| NorthStar Rx LLC | 1 | $0.07811 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.07811 per EA filed |
All 16 NDCs, with labeler and price
- 00904-6552-61 · Major Pharmaceuticals · $0.07811 per EA · eff. 2026-09-23 filed
- 16714-0160-01 · NorthStar Rx LLC · $0.07811 per EA · eff. 2026-09-23 filed
- 50268-0622-11 · not listed as a package in the FDA directory · $0.07811 per EA · eff. 2026-09-23 filed
- 50268-0622-15 · AvPAK · $0.07811 per EA · eff. 2026-09-23 filed
- 55111-0154-30 · Dr. Reddy's Laboratories Limited · $0.07811 per EA · eff. 2026-09-23 filed
- 57237-0076-30 · Rising Pharma Holdings, Inc. · $0.07811 per EA · eff. 2026-09-23 filed
- 57237-0076-50 · Rising Pharma Holdings, Inc. · $0.07811 per EA · eff. 2026-09-23 filed
- 62135-0351-05 · Chartwell RX, LLC · $0.07811 per EA · eff. 2026-09-23 filed
- 62135-0351-30 · Chartwell RX, LLC · $0.07811 per EA · eff. 2026-09-23 filed
- 65862-0188-03 · Aurobindo Pharma Limited · $0.07811 per EA · eff. 2026-09-23 filed
- 65862-0188-30 · Aurobindo Pharma Limited · $0.07811 per EA · eff. 2026-09-23 filed
- 68084-0221-01 · American Health Packaging · $0.07811 per EA · eff. 2026-09-23 filed
- 68084-0221-11 · not listed as a package in the FDA directory · $0.07811 per EA · eff. 2026-09-23 filed
- 68462-0106-30 · Glenmark Pharmaceuticals Inc., USA · $0.07811 per EA · eff. 2026-09-23 filed
- 69339-0172-01 · Natco Pharma USA LLC · $0.07811 per EA · eff. 2026-09-23 filed
- 69339-0172-03 · Natco Pharma USA LLC · $0.07811 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
6 other products in the NADAC file share an FDA nonproprietary name with ONDANSETRON HCL 8 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ONDANSETRON 4 MG/5 ML SOLUTION | $0.28641 per ML filed | $0.0128 per ML derived |
| ONDANSETRON 40 MG/20 ML VIAL | $0.17297 per ML filed | $0.168 per ML derived |
| ONDANSETRON HCL 4 MG TABLET | $0.05824 per EA filed | $0.064 per EA derived |
| ONDANSETRON HCL 4 MG/2 ML VIAL | $0.17588 per ML filed | $0.168 per ML derived |
| ONDANSETRON HCL 8 MG TABLET this page | $0.07811 per EA filed | $0.128 per EA derived |
| ONDANSETRON ODT 4 MG TABLET | $0.11992 per EA filed | $0.50024 per EA filed |
| ONDANSETRON ODT 8 MG TABLET | $0.16863 per EA filed | $0.50024 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
OpenBill calculation · october-2026-medicare-part-b-payment-limit-files-final.zip + october-2026-ndc-hcpcs-crosswalk-final.zip · Part B limit 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18) · Part B crosswalk 2026-10-01 to 2026-12-31 (file of 2026-09-17, retrieved 2026-10-18)
Compared with its class
The middle of its 16 NDCs’ NADAC prices is $0.07811 per EA filed.
Of the 7 other products in FDA’s Serotonin-3 Receptor Antagonist class priced per EA, 6 have a higher middle NADAC price and 1 a lower one. The one in the middle is GRANISETRON HCL 1 MG TABLET, at $1.30504 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part B’s payment limit for HCPCS Q0162, for 2026-10-01 to 2026-12-31, comes to $3.84 for 30 tablets, or $0.128 per EA once converted to NADAC’s unit for this product.
Medicare Part B pays for this oral drug at a pharmacy only in specific circumstances CMS sets for this code; most prescriptions are paid by Part D.
The patient’s share under Part B (coinsurance, 20% of the limit, before deductibles and other coverage) is $0.0032 per 1 MG.
8 of the product’s 16 NDCs have this Medicare figure; the other 8 do not, and the interactive card says why for each.
Medicare's price is not your price.
What the Part B payment limit is · Converting it to the NADAC unit · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part B: is this drug covered for me in this setting, and what is my share?
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.